Observing People With Desmoid-Type Fibromatosis

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

February 19, 2026

Study Completion Date

February 19, 2026

Conditions
Desmoid Fibromatosis
Interventions
DIAGNOSTIC_TEST

Cross-sectional imaging

MRI with gadolinium contrast will be the imaging modality of choice. In patients with contraindications to MRI who instead undergo baseline evaluation by CT scan, tumor evaluation will be by serial CT scans with IV contrast throughout the study period.

Trial Locations (1)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER